MTOR and metastatic melanoma: Interestingly, analyzing 31 candidate genes existing in either the PI3K or MAPK pathway in 105 metastatic melanoma patients, the researchers found two novel nonsynonymous mutations (R2443∗ and L552F) in MTOR gene (Shull et al., 2012).